5-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)benzo[d]thiazole Chemical Properties

Boiling point:

380.6±15.0 °C(Predicted)

Density 

1.17±0.1 g/cm3(Predicted)

storage temp. 

under inert gas (nitrogen or Argon) at 2-8°C

pka

0.60±0.10(Predicted)

InChI

InChI=1S/C13H16BNO2S/c1-12(2)13(3,4)17-14(16-12)9-5-6-11-10(7-9)15-8-18-11/h5-8H,1-4H3

InChIKey

MGOKEBHEDJCRQN-UHFFFAOYSA-N

SMILES

S1C2=CC=C(B3OC(C)(C)C(C)(C)O3)C=C2N=C1

Safety Information

HS Code 

2934208090

5-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)benzo[d]thiazole Usage And Synthesis

Synthesis

A mixture was prepared from 5-bromobenzo[d]thiazole (428 mg, 2.00 mmol), bis(pinacolato)diboron (558 mg, 2.20 mmol) and potassium acetate (588 mg, 6.00 mmol) in dimethylsulfoxide (7 mL). The mixture was stirred under nitrogen protection for 5 min. Subsequently, [1,1'-bis(diphenylphosphino)ferrocene]palladium(II) dichloride dichloromethane complex (293 mg, 0.40 mmol) was added and the reaction mixture was stirred for 3 hours at 85 °C. Upon completion of the reaction, the mixture was filtered through a diatomaceous earth pad and the filter cake was washed with ethyl acetate (75 mL) followed by water (20 mL). The filtrate was diluted with ethyl acetate (100 mL) and washed sequentially with water (2 x 75 mL) and brine (75 mL). The organic phase was dried with anhydrous sodium sulfate, filtered and concentrated under reduced pressure. The residue was purified by column chromatography (silica gel as stationary phase, eluent was a mixture of dichloromethane and ethyl acetate, gradient elution, volume fraction of ethyl acetate was increased from 0% to 50%) to afford the target product 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[d]thiazole (200 mg, 38% yield) as a light brown solid. The structure of the product was confirmed by 1H NMR (300 MHz, DMSO-d6) and ESI MS: 1H NMR δ 9.41 (s, 1H), 8.32 (s, 1H), 8.18 (d, 1H, J = 8.0 Hz), 7.72 (d, 1H, J = 8.0 Hz), 1.33 (s, 12H); ESI MS m/z 262.1 [M + H ]+.

References

[1] Patent: WO2010/68257, 2010, A1. Location in patent: Page/Page column 92-93
[2] Patent: WO2009/14637, 2009, A2. Location in patent: Page/Page column 173-174
[3] Patent: WO2011/66211, 2011, A1. Location in patent: Page/Page column 86-87
[4] Patent: CN108707139, 2018, A. Location in patent: Paragraph 0612; 0614; 0655; 0656; 0657; 0658

5-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)benzo[d]thiazole(1073354-91-2)Related Product Information

• Benzothiazole-2-acetonitrile
• 2-Aminobenzo[b]thiophene
• Benzimidazole-5,6-dicarboxylic acid
• 2-(Benzofuran-2-yl)-6-methyl-1,3,6,2-dioxazaborocane-4,8-dione, 2-Benzofuranboronic acid MIDA ester
• (1H-BENZOIMIDAZOL-2-YL)-ACETIC ACID
• METHYL BENZO[B]THIOPHENE-2-CARBOXYLATE
• Benzomorpholine
• BENZOFURAN-3-BORONIC ACID